Testimonials

Mariah's Story

Todd's Story

NeuroStar Advanced Treatment

Dear Current or Potential Patient, we want to update you on medical advancements at our practice. We now offer a proven treatment option for adults who have depression. NeuroStar Advanced Therapy may provide relief when depression does not respond to antidepressant therapy.1

What Is NeuroStar Advanced Treatment?

NeuroStar treatment uses a magnet to stimulate nerve cells in the brain that may impact mood. This magnet delivers pulses with similar strength as an MRI machine. Scientists think this treatment could increase the brain’s neurotransmitter levels.2,3,4,5 This may promote long-term recovery from depression.6 More than 2.5 million NeuroStar treatments have been done across the U.S.7 Every day, more people receive hope from this proven approach for depression.

Treatment with NeuroStar Advanced Therapy is easy:

  • Treatment sessions are done in our office.
  • You can return to normal activities right away.
  • You are awake during treatment.
  • Your memory and sleep will not be affected.8
  • It’s covered by most health insurance plans.

Does It Work? Is It Safe?

NeuroStar Advanced Therapy was cleared by the FDA in 2008. NeuroStar is backed by more clinical studies for depression than any other type of transcranial magnetic stimulation (TMS) therapy. Trials with 900 patients have shown that NeuroStar Advanced Therapy can help patients living with depression achieve remission.7 Learn more at www.neurostar.com

If you or someone you know is suffering from depression, contact our office today to schedule a consultation (817) 283-7400 or drshannonajohnson@gmail.com

Yours Truly,

Shannon A. Johnson, M.D.

 

 

 

  1. Janicak PG, et al. (2008). J Clin Psychiatry, 69(2): 222-232.
  2. Kanno M, Matsumoto M, et al. J Neurological Sciences. 2004; 217:73-81.
  3. Juckel G, Mendlin MA, et al. Neuropsychopharmacology. 1999; 21(3): 391-398.
  4. Slotema CW, Blom JD, et al. J Clin Psychiatry. 2010; 71(7):873-884.
  5. Kito, S, Fujita, K, Koga, Y. J Neuropsychiatry Clin Neurosci. 2008; 20(1): 74-80.
  6. Dunner DL, et al, (2014) J Clin Psychiatry, 75(12): 1394-1401.
  7. Neuronetics, Inc. Data on File
  8. Rosenquist PB, et. al (2013), Psychiatry Res 205(1-2)67-73.